http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2721623-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65615 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6547 |
| filingDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6136609d7394a31a051c3f7923123781 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_508357d9ec2aae84f55e0da09819efea |
| publicationDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2721623-T3 |
| titleOfInvention | Novel procedure for the preparation of ceftaroline fosamil |
| abstract | Compound having the formula (1) ** (See formula) ** in which Phos is a phosphate group; and X is a cation selected from the group consisting of a magnesium cation and an imidazolium cation that can be optionally substituted by one or more C1-6 alkyl groups, in which, if the cation is an imidazolium cation, the phosphate group is ** (See formula) ** and if the cation is a magnesium cation, then the phosphate group is ** (See formula) ** as well as a pharmaceutically acceptable solvate thereof. |
| priorityDate | 2012-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.